Clinical Trial: A Pilot Study of Induction at 39 Weeks to Reduce Cesarean in Low - Risk Women in China

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082530) titled 'A Pilot Study of Induction at 39 Weeks to Reduce Cesarean in Low - Risk Women in China' on June 25.

Brief Summary: The investigators are committed to identifying the optimal timing of delivery for low-risk pregnancies. While current guidelines typically recommend induction at 41 weeks, emerging evidence suggests that elective induction at 39 weeks may lead to improved maternal and neonatal outcomes. The U.S.-based ARRIVE trial demonstrated that induction at 39 weeks significantly reduced cesarean delivery rates compared to expectant management, and a similar randomized controlled trial (French-ARRIVE) is ongoing in France. However, ...